Literature DB >> 21479463

Increased number of FoxP3+CD4+ regulatory T cells in inflammatory bowel disease.

Hiromitsu Ban1, Akira Andoh, Makoto Shioya, Atsushi Nishida, Tomoyuki Tsujikawa, Yoshihide Fujiyama.   

Abstract

FoxP3 is a member of the forkhead/winged helix family of transcription factors and plays a critical role in the development and function of CD4+CD25+ regulatory T cells (Tregs). In this study, we performed an immunohistochemical evaluation of FoxP3-expressing cells in inflammatory bowel disease (IBD) mucosa. Mucosal FoxP3 expression was evaluated by immunohistochemistry in samples from normal (n=30), ulcerative colitis (UC) (n=53) and Crohn's disease (CD) (n=24) mucosa. There were no FoxP3-immunopositive cells in the normal colonic mucosa. In contrast, FoxP3-immunopositive cells were significantly increased in the inflamed regions of patients with active UC and CD. FoxP3-immunopositive cells completely coincided with some of the CD4-positive T cells. In conclusion, FoxP3-immunopositive Tregs were expanded in the inflamed mucosa of IBD patients. This suggests that these cells have impaired regulatory functions in the IBD mucosa.

Entities:  

Year:  2008        PMID: 21479463     DOI: 10.3892/mmr_00000006

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  13 in total

Review 1.  Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.

Authors:  Mohammad Salem; Jakob Benedict Seidelin; Gerhard Rogler; Ole Haagen Nielsen
Journal:  Cell Mol Life Sci       Date:  2012-12-29       Impact factor: 9.261

2.  Crossover Subsets of CD4+ T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn's Disease and Ulcerative Colitis.

Authors:  Ji Li; Aito Ueno; Marietta Iacucci; Miriam Fort Gasia; Humberto B Jijon; Remo Panaccione; Gilaad G Kaplan; Paul L Beck; Joanne Luider; Herman W Barkema; Jiaming Qian; Xianyong Gui; Subrata Ghosh
Journal:  Dig Dis Sci       Date:  2017-06-01       Impact factor: 3.199

3.  Frequencies of circulating regulatory TIGIT+CD38+ effector T cells correlate with the course of inflammatory bowel disease.

Authors:  Maria E Joosse; Celia L Menckeberg; Lilian F de Ruiter; H Rolien C Raatgeep; Lisette A van Berkel; Ytje Simons-Oosterhuis; Irma Tindemans; A Femke M Muskens; Rudi W Hendriks; Remco M Hoogenboezem; Tom Cupedo; Lissy de Ridder; Johanna C Escher; Sharon Veenbergen; Janneke N Samsom
Journal:  Mucosal Immunol       Date:  2018-08-20       Impact factor: 7.313

Review 4.  Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases.

Authors:  Anja A Kühl; Ulrike Erben; Lea I Kredel; Britta Siegmund
Journal:  Front Immunol       Date:  2015-12-07       Impact factor: 7.561

5.  The Expression of T Cell FOXP3 and T-Bet Is Upregulated in Severe but Not Euthyroid Hashimoto's Thyroiditis.

Authors:  Stana Tokić; Mario Štefanić; Ljubica Glavaš-Obrovac; Sonja Jaman; Eva Novosadová; Jana Petrkova; Zdenka Navratilova; Mirjana Suver Stević; Martin Petrek
Journal:  Mediators Inflamm       Date:  2016-07-05       Impact factor: 4.711

6.  Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice.

Authors:  Ann-Kathrin Uhde; Vanessa Herder; Muhammad Akram Khan; Malgorzata Ciurkiewicz; Dirk Schaudien; René Teich; Stefan Floess; Wolfgang Baumgärtner; Jochen Huehn; Andreas Beineke
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

7.  Mucosal Immunity Related to FOXP3+ Regulatory T Cells, Th17 Cells and Cytokines in Pediatric Inflammatory Bowel Disease.

Authors:  Jinhee Cho; Sorina Kim; Da Hee Yang; Juyeon Lee; Kyeong Won Park; Junyong Go; Chang-Lim Hyun; Youngheun Jee; Ki Soo Kang
Journal:  J Korean Med Sci       Date:  2018-12-10       Impact factor: 2.153

8.  Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn's Disease.

Authors:  Kristina L Leinwand; Ashleigh A Jones; Rick H Huang; Paul Jedlicka; Daniel J Kao; Edwin F de Zoeten; Soumita Ghosh; Ruin Moaddel; Jan Wehkamp; Maureen J Ostaff; Jutta Bader; Carol M Aherne; Colm B Collins
Journal:  J Crohns Colitis       Date:  2017-10-27       Impact factor: 9.071

9.  CD4+ CD25+ FOXP3+ T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn's disease.

Authors:  Veena Tiwari; Saurabh Kedia; Sushil Kumar Garg; Ritika Rampal; V Pratap Mouli; Anuja Purwar; D K Mitra; Prasenjit Das; S Dattagupta; Govind Makharia; S K Acharya; Vineet Ahuja
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

10.  Targeting sirtuin-1 alleviates experimental autoimmune colitis by induction of Foxp3+ T-regulatory cells.

Authors:  T Akimova; H Xiao; Y Liu; T R Bhatti; J Jiao; E Eruslanov; S Singhal; L Wang; R Han; K Zacharia; W W Hancock; U H Beier
Journal:  Mucosal Immunol       Date:  2014-02-19       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.